The Nano4 project takes fast, reliable and low-cost molecular point of care (POC) diagnostic tools down to the nano-scale, offering better healthcare outcomes for patients.
Medics working in migratory hotspots, in countries with low laboratory infrastructure or in other demanding situations often need to be able to screen large populations quickly, in a non-centralised manner. Patients who would be more comfortable not having to travel far to be screened, and those with conditions which demand swift action, such as suspected chronic myeloid leukaemia, would also benefit.
The EU-funded Nano4 project has developed a fast, accurate, low-cost, point-of-care diagnostic for certain viruses, pathogens and cancer-types. The technology will help healthcare decision-makers to act quickly, save lives, reduce pain and avoid mistakes. It could even prevent epidemics.